DIAGNOS-est-reconnue-comme-lune-des-meilleures-societes-de-la-Bourse-de-croissance-TSX
DIAGNOS-est-reconnue-comme-lune-des-meilleures-societes-de-la-Bourse-de-croissance-TSX
DIAGNOS-Q3-2024-MDA-1
DIAGNOS-Q3-2024-MDA-1
DIAGNOS-Announces-Closing-of-First-Tranche-of-Private-Placement-1
DIAGNOS-Announces-Closing-of-First-Tranche-of-Private-Placement-1
DIAGNOS-Announces-Change-in-One-Insider-Ownership-1
DIAGNOS-Announces-Change-in-One-Insider-Ownership-1
DIAGNOS-Announces-Closing-of-First-Tranche-of-Private-Placement
DIAGNOS-Announces-Closing-of-First-Tranche-of-Private-Placement
DIAGNOS-Announces-Grant-of-Stock-Options
DIAGNOS-Announces-Grant-of-Stock-Options
DIAGNOS-Welcomes-Dr.-Philippe-Couillard-to-its-Board-of-Directors
DIAGNOS-Welcomes-Dr.-Philippe-Couillard-to-its-Board-of-Directors
DIAGNOS-inc.-presentera-a-la-conference-des-investisseurs-hybrides-AI-Technologie-le-11-avril
DIAGNOS-inc.-presentera-a-la-conference-des-investisseurs-hybrides-AI-Technologie-le-11-avril
DIAGNOS-accelerera-la-demande-de-licence-dinstrument-medical-a-Sante-Canada-et-a-la-FDA-des-Etats-Unis-concernant-ses-4-nouveaux-modules-danalyse^J-et-prevoit-la-certification-ISO-27001
DIAGNOS-accelerera-la-demande-de-licence-dinstrument-medical-a-Sante-Canada-et-a-la-FDA-des-Etats-Unis-concernant-ses-4-nouveaux-modules-danalyse^J-et-prevoit-la-certification-ISO-27001
DIAGNOS-annonce-un-octroi-doptions-dachat-dactions
DIAGNOS-annonce-un-octroi-doptions-dachat-dactions
